EMJ Hepatology 14 [Supplement 1] . 2026

In this issue

Despite combination prophylaxis with HBIG and NUCs transforming outcomes after liver transplantation for hepatitis B, some studies have suggested a shift to NUC monotherapy. Yet with HBV recurrence being closely linked to hepatocellular carcinoma recurrence, is this really the best approach?